Charmacy Pharmaceutical Co., Ltd.
HKEX:2289.HK
9.3 (HKD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| 51.345 | 90.38 | 23.153 | 40.556 | 40.153 | 45.433 | 44.76 | 56.458 | 26.359 | 36.445 | 22.219 |
| Depreciation & Amortization
| 26.47 | 28.837 | 32.035 | 24.552 | 23.939 | 18.441 | 14.122 | 11.478 | 8.982 | 9.725 | 9.967 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 237.372 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0.989 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -219.31 | -300.21 | 20.941 | -227.853 | -43.839 | 6.217 | -238.361 | -137.237 | -234.268 | -134.608 | -223.378 |
| Accounts Receivables
| -98.174 | -222.467 | -54.811 | -158.029 | -0.817 | 47.347 | -157.763 | -105.388 | -160.866 | -145.475 | -178.023 |
| Inventory
| -193.349 | -77.743 | 75.752 | -69.824 | -43.023 | -41.129 | -80.598 | -31.849 | -73.402 | 10.867 | -45.355 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 72.213 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| 44.957 | 225.043 | -95.673 | 293.821 | -16.235 | -20.94 | 145.531 | -32.251 | 392.597 | 73.612 | 236.296 |
| Operating Cash Flow
| -96.538 | 44.05 | -19.543 | 131.077 | 4.019 | 49.151 | -32.96 | -101.551 | 193.67 | -14.826 | 45.104 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -40.849 | -8.589 | -25.04 | -51.982 | -73.903 | -97.726 | -125.625 | -19.574 | -2.153 | -4.447 | -5.104 |
| Acquisitions Net
| 0 | 0 | 0 | -2.856 | 0 | 0 | 2.086 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | -0.1 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 80.186 | 80.351 | 0.638 | 0.058 | 0.16 | 0.157 | 0.177 | 0.037 | -165.717 | 45.35 | -56.601 |
| Investing Cash Flow
| 39.337 | 71.762 | -24.402 | -54.78 | -73.744 | -97.569 | -123.362 | -19.537 | -167.87 | 40.903 | -61.705 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 74.3 | -245.029 | 137.476 | 65.412 | 206.524 | 22.009 | 242.919 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 188.332 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -75.5 | -28.44 | -52.494 | -56.512 | -61.575 | -48.36 | -51.084 | -21.139 | -46 | 0 | 0 |
| Other Financing Activities
| 102.462 | 82.258 | -10.582 | -11.577 | -90.823 | 55.511 | -78.216 | 116.694 | -34.799 | -20.542 | 21.016 |
| Financing Cash Flow
| 101.262 | -191.212 | 74.401 | -2.676 | 54.127 | 29.16 | 113.618 | 79.592 | 107.533 | -20.542 | 21.016 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0.006 | 0.033 | 0 | 0.001 | 0.009 | -0.101 | -1.768 | 5.926 | 0 | 0 | 12.346 |
| Net Change In Cash
| 44.067 | -75.365 | 30.455 | 73.622 | -15.589 | -19.358 | -44.472 | -36.06 | 133.333 | 5.535 | 16.761 |
| Cash At End Of Period
| 112.929 | 68.861 | 144.227 | 113.771 | 40.149 | 55.739 | 75.097 | 119.569 | 155.629 | 22.296 | 16.761 |